REG-Acquisition of Own Shares
Lakefront Biotherapeutics repurchased 107,804 shares between October 12 and October 16, 2026, spending €2,854,365.69 at an average price of €26.48 per share. The purchases were executed via a discretionary mandate to an independent financial intermediary across Euronext markets, and as of October 16 the company holds 1,985,157 of its own ordinary shares.
Key figures
- Program status
- fully completed
- Average price eur
- 26.48
- Shares repurchased week
- 107804
- Total shares held treasury
- 1985157
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.